These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37713805)

  • 21. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxetanes from the ring contraction of alpha-triflates of gamma-lactones: oxetane nucleosides and oxetane amino acids.
    Jenkinson SF; Fleet GW
    Chimia (Aarau); 2011; 65(1-2):71-5. PubMed ID: 21469449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Oxetane-Based Polyketide Surrogate To Probe Substrate Binding in a Polyketide Synthase.
    Ellis BD; Milligan JC; White AR; Duong V; Altman PX; Mohammed LY; Crump MP; Crosby J; Luo R; Vanderwal CD; Tsai SC
    J Am Chem Soc; 2018 Apr; 140(15):4961-4964. PubMed ID: 29620883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors.
    Stepan AF; Karki K; McDonald WS; Dorff PH; Dutra JK; Dirico KJ; Won A; Subramanyam C; Efremov IV; O'Donnell CJ; Nolan CE; Becker SL; Pustilnik LR; Sneed B; Sun H; Lu Y; Robshaw AE; Riddell D; O'Sullivan TJ; Sibley E; Capetta S; Atchison K; Hallgren AJ; Miller E; Wood A; Obach RS
    J Med Chem; 2011 Nov; 54(22):7772-83. PubMed ID: 21995460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxetanes as promising modules in drug discovery.
    Wuitschik G; Rogers-Evans M; Müller K; Fischer H; Wagner B; Schuler F; Polonchuk L; Carreira EM
    Angew Chem Int Ed Engl; 2006 Nov; 45(46):7736-9. PubMed ID: 17013952
    [No Abstract]   [Full Text] [Related]  

  • 26. C-H Insertion as a Key Step to Spiro-Oxetanes, Scaffolds for Drug Discovery.
    Nicolle SM; Nortcliffe A; Bartrum HE; Lewis W; Hayes CJ; Moody CJ
    Chemistry; 2017 Oct; 23(55):13623-13627. PubMed ID: 28796404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Products Containing the Oxetane and Related Moieties Present Additional Challenges for Structure Elucidation: A DU8+ Computational Case Study.
    Kutateladze AG; Holt T; Reddy DS
    J Org Chem; 2019 Jun; 84(12):7575-7586. PubMed ID: 31145850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorine in medicinal chemistry.
    Swallow S
    Prog Med Chem; 2015; 54():65-133. PubMed ID: 25727703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of oxetane incorporation on the structure and stability of alpha-helical peptides.
    Jayawant ES; Beadle JD; Wilkening I; Raubo P; Shipman M; Notman R; Dixon AM
    Phys Chem Chem Phys; 2020 Nov; 22(43):25075-25083. PubMed ID: 33118559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxetane Grafts Installed Site-Selectively on Native Disulfides to Enhance Protein Stability and Activity In Vivo.
    Martínez-Sáez N; Sun S; Oldrini D; Sormanni P; Boutureira O; Carboni F; Compañón I; Deery MJ; Vendruscolo M; Corzana F; Adamo R; Bernardes GJL
    Angew Chem Int Ed Engl; 2017 Nov; 56(47):14963-14967. PubMed ID: 28968001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: a medicinal chemistry perspective.
    Kumar S; Sharma R; Roychowdhury A
    Curr Med Chem; 2012; 19(21):3605-21. PubMed ID: 22680629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of oxetane and azetidine ethers as ester isosteres by Brønsted acid catalysed alkylation of alcohols with 3-aryl-oxetanols and 3-aryl-azetidinols.
    Saejong P; Rojas JJ; Denis C; White AJP; Voisin-Chiret AS; Choi C; Bull JA
    Org Biomol Chem; 2023 Jul; 21(27):5553-5559. PubMed ID: 37345459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photoinduced electron transfer cleavage of oxetane adducts of uracil and cytosine.
    Joseph A; Falvey DE
    Photochem Photobiol Sci; 2002 Sep; 1(9):632-5. PubMed ID: 12665298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxy-group effect on the regioselectivity in a photochemical oxetane formation reaction (the Paternò-Büchi Reaction) of geraniol derivatives.
    Hisamoto K; Hiraga Y; Abe M
    Photochem Photobiol Sci; 2011 Sep; 10(9):1469-73. PubMed ID: 21541429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Overview of Saturated Cyclic Ethers: Biological Profiles and Synthetic Strategies.
    Lu Q; Harmalkar DS; Choi Y; Lee K
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31640154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino-oxetanes as amide isosteres by an alternative defluorosulfonylative coupling of sulfonyl fluorides.
    Rojas JJ; Croft RA; Sterling AJ; Briggs EL; Antermite D; Schmitt DC; Blagojevic L; Haycock P; White AJP; Duarte F; Choi C; Mousseau JJ; Bull JA
    Nat Chem; 2022 Feb; 14(2):160-169. PubMed ID: 35087220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of sulfur-containing motifs in drug design and discovery.
    Mustafa M; Winum JY
    Expert Opin Drug Discov; 2022 May; 17(5):501-512. PubMed ID: 35193437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Allylic Strain for Conformational Control in Medicinal Chemistry.
    Zhao H; Brånalt J; Perry M; Tyrchan C
    J Med Chem; 2023 Jun; 66(12):7730-7755. PubMed ID: 37285219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicinal Chemistry Projects Requiring Imaginative Structure-Based Drug Design Methods.
    Moitessier N; Pottel J; Therrien E; Englebienne P; Liu Z; Tomberg A; Corbeil CR
    Acc Chem Res; 2016 Sep; 49(9):1646-57. PubMed ID: 27529781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.